Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06547892 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

Study acronym: NOVA-AKI
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 13, 2025 (before its estimated October 10, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Aug 14, 2025 to Oct 10, 2025
    • Study completion date: Oct 14, 2025 to Dec 10, 2025
    • Start date changed from estimate of Apr 14, 2025 to Apr 10, 2025
    • Site details revised
  2. Primary completion date: Jan 2025 to Aug 14, 2025
    • Start date: Sep 2024 to Apr 14, 2025
    • Study completion date: Jul 2025 to Oct 14, 2025
    • Eligibility criteria expanded, about 13 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Renal dysfunction is a frequent complication in patients admitted to intensive care units (ICUs), associated with high morbidity and mortality. Current therapeutic options to prevent this condition are limited and lack robust scientific evidence. This pilot study consists of a multicenter, blinded, randomized clinical trial, unprecedented in the literature to date, aiming to fill this knowledge gap and offer new therapeutic perspectives to improve renal outcomes in critically ill patients admitted to the ICU.
Trial Details
NCT Number NCT06547892
Lead Sponsor Hospital do Coracao
Conditions
(from sponsor)		 Critical Illness
Related terms Critical Illness
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov